Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
August 09 2024 - 3:14PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rules 13a-16 or 15d-16 under
the Securities Exchange Act of 1934
For the month of August 2024
Commission File Number: 001-41586
MOOLEC SCIENCE SA
(Exact name of Registrant as Specified in Its Charter)
17, Boulevard F. W. Raiffeisen
L-2411 Luxembourg,
Grand Duchy of Luxembourg
(Address of principal executive offices)
Indicate by check mark whether the registrant files
or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒
Form 40-F ☐
Exhibit List
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
MOOLEC SCIENCE SA |
|
(Registrant) |
|
|
|
Dated: August 9, 2024 |
By: |
/s/ Gastón
Paladini |
|
Name: |
Gastón Paladini |
|
Title: |
Chief Executive Officer |
2
Exhibit 99.1
Moolec and Bunge
Sign Research & Collaboration Agreement
Buenos
Aires, August 6, 2024 - Moolec Science Limited SE, a subsidiary of Moolec Science SA (NASDAQ: MLEC) in Argentina (hereinafter, “Moolec”),
a science-driven food ingredient company focused on producing animal proteins in plants through “Molecular Farming” technology;
and Bunge Argentina SA (“Bunge”), a subsidiary of Bunge Global SA (NYSE: BG) and a global leader in agribusiness and food,
today announced the signing of a collaboration agreement to work together on developing safflower varieties to improve their productivity
for specific applications and markets, such as biofuels.
In a collaboration, Bunge and Moolec have embarked
on a joint project aimed at unlocking the full potential of safflower in various applications and opportunities. This strategic partnership
leverages Bunge’s unmatched scale, industrialization power, and extensive product development capabilities, providing a solid foundation
for the success of the joint program. Moolec, known for driving innovation and disruption in biotechnology, brings cutting-edge expertise,
addressing sustainability challenges in the industry, and pioneering a new era of agricultural solutions. Together, Moolec and Bunge are
poised to make significant strides toward a more sustainable and resilient future for the global agricultural landscape.
Jorge Bassi, New Business Development Manager
in Argentina, stated: “At Bunge, we continuously seek new sustainable options for raw materials destined for biofuels. We are
excited about the potential to collaborate with Moolec on the upcoming safflower and soybean crop project.”
Martín Salinas, Chief Technology Officer
and Co-founder of Moolec, said: “The successful development of these innovative safflower varieties will allow Moolec to expand
its safflower-based technology portfolio and platform, potentially leading to advances in our molecular safflower cultivation products,
which will soon reach global markets.” He later concluded: “The new traits incorporated in the latest varieties open up production
possibilities in places where safflower’s potential has not yet been fully realized. This marks a significant advance in our mission
to unlock new pathways for agricultural productivity.”
Safflower, chosen for its favorable target oil
composition, is an ideal candidate for innovation. The existing strong base of safflower producers, along with its well-known identity
preservation management, further enhances the efficiency and viability of the collaboration efforts. Safflower’s inherent drought
tolerance, particularly beneficial for complementary production sites, adds a layer of resilience to the agricultural landscape.
The results of the collaboration between the two
companies aim to achieve improvements, modifications, and alterations resulting in new safflower varieties, as well as the information
and data generated during the project.
Moolec Science (NASDAQ:MLECW)
Historical Stock Chart
From Jan 2025 to Feb 2025
Moolec Science (NASDAQ:MLECW)
Historical Stock Chart
From Feb 2024 to Feb 2025